[Fibrinolytic treatment of peripheral artery disease and phlebothrombosis (author's transl)].
Standardised streptokinase-heparin treatment was used in 30 patients with stenoses or occlusions of the large arteries and phlebothrombosis. Apart from three cases of occlusion of the popliteal artery it was possible to revascularise all occluded vessels and markedly widen any haemodynamically effective stenoses.
D000328:Adult; D000368:Aged; D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D005263:Femoral Artery; D005268:Femoral Vein; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007083:Iliac Artery; D007084:Iliac Vein; D008875:Middle Aged; D011150:Popliteal Artery; D013300:Streptokinase / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D013350:Subclavian Vein; D013924:Thrombophlebitis / Q000188:drug therapy*; D013997:Time Factors
D006493:Heparin; D013300:Streptokinase
Die fibrinolytische Therapie bei arterieller Verschlusskrankheit und Phlebothrombosen